Results 141 to 150 of about 187,393 (277)
Streptococcus agalactiae [PDF]
openaire +2 more sources
A total of 125 random samples of raw milk and soft cheese (25 each) of cow's milk, sheep's milk, goat's milk, kareish cheese and Domiati cheese samples were collected from different markets and shops in Alexandria city, Egypt and examined for the ...
Hanaa El-Mossalami, Nevein Hamed
doaj +1 more source
Multiplex PCR for simultaneous detection of Streptococcus agalactiae, Streptococcus iniae and Lactococcus garvieae: a case of S. agalactiae infection in cultured Nile tilapia (Oreochromis niloticus) and red tilapia (Oreochromis niloticus x Oreochromis mossambicus) [PDF]
A multiplex PCR (m-PCR) technique was developed for simultaneous detection of the causative agents responsible forstreptococcosis of cultured fish in Thailand i.e., Streptococcus agalactiae, Streptococcus iniae, and Lactococcus garvieae.The study on the ...
Chutima Tantikitti+2 more
doaj
Identification and characterization of dominant microflora isolated from selected ripened cheese varieties produced in Uganda [PDF]
In this study, the predominant lactic acid bacteria (LAB) isolates were obtained from Gouda, Jack, Cheddar, and Parmesan cheeses produced in Uganda. The isolates were identified through Gram staining, catalase and oxidase tests, and 16S rDNA sequencing.
arxiv
Resumen: Introducción: El Streptococcus agalactiae (S. agalactiae) es un germen frecuentemente colonizador asintomático y causante de sepsis neonatal y puerperal. Las infecciones en adultos, fuera del embarazo, son poco frecuentes.
B. Oyanguren+7 more
doaj
Introduction: Streptococcus agalactiae is frequently an asymptomatic coloniser and a cause of neonatal and puerperal sepsis. Infections in non-pregnant adults are uncommon.
B. Oyanguren+7 more
doaj
Molecular analysis of lipoteichoic acid from Streptococcus agalactiae [PDF]
J J Maurer, S J Mattingly
openalex +1 more source
Genomic Diversity amongStreptococcus agalactiaeIsolates Detected by a Degenerate Oligonucleotide‐Primed Amplification Assay [PDF]
Adriana S. Limansky+4 more
openalex +1 more source
A Surrogate Endpoint Based Provisional Approval Causal Roadmap [PDF]
For many rare diseases with no approved preventive interventions, promising interventions exist, yet it has been difficult to conduct a pivotal phase 3 trial that could provide direct evidence demonstrating a beneficial effect on the target disease outcome.
arxiv